12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several health care stocks showed notable movements. Cue Health, Aclarion, BioSig Technologies, OptiNose, SCWorx, and Avenue Therapeutics were among the gainers, with Cue Health leading with a 12.1% increase following its Q4 earnings release. On the downside, Molecular Templates, Better Therapeutics, PaxMedica, Aligos Therapeutics, Autolus Therapeutics, and Mersana Therapeutics experienced declines, with Molecular Templates dropping 12.7%. Earnings reports influenced some of these movements.
March 15, 2024 | 9:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aligos Therapeutics' stock declined by 5.26% to $0.9 after its Q4 earnings report, with a market cap of $68.1 million.
Aligos Therapeutics' stock price drop is likely linked to its Q4 earnings report, which may have not met investor expectations.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Autolus Therapeutics' shares decreased by 4.99% to $5.53 after releasing its Q4 earnings, with a market cap of $1.2 billion.
The decrease in Autolus Therapeutics' stock price can be attributed to its recent Q4 earnings announcement, potentially not meeting market expectations.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Molecular Templates' shares fell 12.7% to $2.4, with a market cap of $12.8 million.
The decline in Molecular Templates' stock price could be attributed to market reactions to recent company performance or sector movements.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Cue Health's stock rose 12.1% to $0.22 after announcing Q4 earnings, with a market cap of $34.8 million.
The positive movement in Cue Health's stock price is likely due to its recent Q4 earnings announcement, which could have exceeded market expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90